Evidence map›Paper›PMID 28572816›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2017

Ergosterol isolated from the basidiomycete

Tatiana Rodrigues Alexandre, Marta Lopes Lima, Mariana Kolos Galuppo, Juliana Tonini Mesquita, Matilia Ana do Nascimento, Augusto Leonardo Dos Santos, Patricia Sartorelli, Daniel Carvalho Pimenta, Andre Gustavo Tempone

Open access · goldAbstract read
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Antibacterial Activity of Extract, Fractions, and Compounds fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Biology · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Triterpenes fromJournal of natural products · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Second-generation pterocarpanquinones: synthesis and antileishmanial activity.The journal of venomous animals and toxins including tropical diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tatiana Rodrigues AlexandreCenter for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8° andar, CEP 01246-000, São Paulo, SP Brazil.
Marta Lopes LimaCenter for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8° andar, CEP 01246-000, São Paulo, SP Brazil.
Mariana Kolos GaluppoCenter for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8° andar, CEP 01246-000, São Paulo, SP Brazil.
Juliana Tonini MesquitaCenter for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8° andar, CEP 01246-000, São Paulo, SP Brazil.
Matilia Ana do NascimentoCenter for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8° andar, CEP 01246-000, São Paulo, SP Brazil.
Augusto Leonardo Dos SantosInstitute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, São Paulo (UNIFESP), Diadema, SP Brazil.
Patricia SartorelliInstitute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, São Paulo (UNIFESP), Diadema, SP Brazil.
Daniel Carvalho PimentaLaboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo, SP Brazil.
Andre Gustavo TemponeCenter for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8° andar, CEP 01246-000, São Paulo, SP Brazil.
Instituto Adolfo Lutz · BRUniversidade Federal de São Paulo · BRInstituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMajor drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs for treating chronic Chagas disease requires immediate action. In this work, we evaluated the mushroom

methodsFruit bodies of the basidiomycete

resultsThe most abundant fraction showing the antiparasitic activity was isolated and chemically elucidated, confirming the presence of ergosterol. It showed anti-

conclusionsThe selection of naturally antiparasitic secondary metabolites in basidiomycetes, such as ergosterol, may provide potential scaffolds for drug design studies against neglected diseases.

Indexed as

ErgosterolMechanism of actionPleurotus salmoneostramineusTrypanosoma cruzi

Identifiers

PMID28572816
PMCPMC5450401
OpenAlexW2618510427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.